NASDAQ · Biotechnology
Arcturus Therapeutics Holdings Inc (ARCT)
$7.45
-1.97%
36
In band
Moving averages
SMA 200$9.09-18.04%
Company profile
Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.
SectorHealthcare
IndustryBiotechnology
Market cap$268.34M
P/E ratioNone
EPS$-3.10
Beta2.605
Dividend yield0.00%
52-week high$17.96
52-week low$5.50
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ALLO
Allogene Therapeutics Inc
RSI 19
DTIL
Precision Biosciences Inc
RSI 45
OCGN
Ocugen Inc
RSI 39
AGEN
Agenus Inc
RSI 44
TRDA
Entrada Therapeutics Inc
RSI 49
EDIT
Editas Medicine Inc
RSI 30
RSI alerts for ARCT
An email when ARCT closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 3:58 AM EST